Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02059408 · ClinicalTrials.gov registry record · NA
Screen-and-treat Program for Chronic Kidney Disease- High Risk Persons
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,819
- Enrollment target
NCT02059408 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,819 participants.
The verdict
NCT02059408, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,819 participants
- Enrollment target
Study Summary
The overall hypothesis of this trial is that screening for chronic kidney disease, followed by education or treatment program will improve blood pressure control among hypertensive non-diabetic persons.
Interventions
- OTHER Screen-Educate
- OTHER Screen-Educate and Intensify Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,819 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02059408
The ClinicalTrials.gov registry entry for NCT02059408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,819 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Screen-Educate is the first listed.
NCT02059408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02059408 about?
NCT02059408 is a clinical study titled "Screen-and-treat Program for Chronic Kidney Disease- High Risk Persons". The overall hypothesis of this trial is that screening for chronic kidney disease, followed by education or treatment program will improve blood pressure control among hypertensive non-diabetic persons.
What is the current status of trial NCT02059408?
This trial is currently completed. It is a NA study. The enrollment target is 1,819 participants. The study started on 2015-09. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02059408?
The interventions under investigation include: Screen-Educate (OTHER), Screen-Educate and Intensify Treatment (OTHER).
Who is sponsoring clinical trial NCT02059408?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.